Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 225

1.

Insulin effects on glucose metabolism, memory, and plasma amyloid precursor protein in Alzheimer's disease differ according to apolipoprotein-E genotype.

Craft S, Asthana S, Schellenberg G, Baker L, Cherrier M, Boyt AA, Martins RN, Raskind M, Peskind E, Plymate S.

Ann N Y Acad Sci. 2000 Apr;903:222-8.

PMID:
10818510
2.

Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype.

Craft S, Asthana S, Cook DG, Baker LD, Cherrier M, Purganan K, Wait C, Petrova A, Latendresse S, Watson GS, Newcomer JW, Schellenberg GD, Krohn AJ.

Psychoneuroendocrinology. 2003 Aug;28(6):809-22.

PMID:
12812866
3.

Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers.

González C, Martín T, Cacho J, Breñas MT, Arroyo T, García-Berrocal B, Navajo JA, González-Buitrago JM.

Eur J Clin Invest. 1999 Jul;29(7):637-42.

PMID:
10411671
4.

The effect of insulin and glucose on the plasma concentration of Alzheimer's amyloid precursor protein.

Boyt AA, Taddei TK, Hallmayer J, Helmerhorst E, Gandy SE, Craft S, Martins RN.

Neuroscience. 2000;95(3):727-34.

PMID:
10670439
5.

Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.

Sunderland T, Mirza N, Putnam KT, Linker G, Bhupali D, Durham R, Soares H, Kimmel L, Friedman D, Bergeson J, Csako G, Levy JA, Bartko JJ, Cohen RM.

Biol Psychiatry. 2004 Nov 1;56(9):670-6.

PMID:
15522251
6.

Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype.

Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D Jr.

Neurology. 1998 Jan;50(1):164-8.

PMID:
9443474
7.

Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease.

Watson GS, Craft S.

Eur J Pharmacol. 2004 Apr 19;490(1-3):97-113. Review.

PMID:
15094077
8.

Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease.

Hashimoto M, Yasuda M, Tanimukai S, Matsui M, Hirono N, Kazui H, Mori E.

Neurology. 2001 Oct 23;57(8):1461-6.

PMID:
11673590
9.
10.

Increased CSF-BACE 1 activity is associated with ApoE-epsilon 4 genotype in subjects with mild cognitive impairment and Alzheimer's disease.

Ewers M, Zhong Z, Bürger K, Wallin A, Blennow K, Teipel SJ, Shen Y, Hampel H.

Brain. 2008 May;131(Pt 5):1252-8. doi: 10.1093/brain/awn034. Epub 2008 Mar 11.

PMID:
18334538
11.

APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.

Fukumoto H, Ingelsson M, Gårevik N, Wahlund LO, Nukina N, Yaguchi Y, Shibata M, Hyman BT, Rebeck GW, Irizarry MC.

Exp Neurol. 2003 Sep;183(1):249-53.

PMID:
12957508
12.

Apolipoprotein E-epsilon 2 and Alzheimer's disease: genotype influences pathologic phenotype.

Lippa CF, Smith TW, Saunders AM, Hulette C, Pulaski-Salo D, Roses AD.

Neurology. 1997 Feb;48(2):515-9.

PMID:
9040748
13.

Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.

Harrington CR, Louwagie J, Rossau R, Vanmechelen E, Perry RH, Perry EK, Xuereb JH, Roth M, Wischik CM.

Am J Pathol. 1994 Dec;145(6):1472-84.

14.

The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions.

Egensperger R, Bancher C, Kösel S, Jellinger K, Mehraein P, Graeber MB.

Biochem Biophys Res Commun. 1996 Jul 16;224(2):484-6.

PMID:
8702415
15.

Apolipoprotein E, memory and Alzheimer's disease.

Soininen HS, Riekkinen PJ Sr.

Trends Neurosci. 1996 Jun;19(6):224-8.

PMID:
8761956
16.

Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects.

Smith GE, Bohac DL, Waring SC, Kokmen E, Tangalos EG, Ivnik RJ, Petersen RC.

Neurology. 1998 Feb;50(2):355-62.

PMID:
9484353
17.

Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage.

McCarron MO, Nicoll JA.

Ann N Y Acad Sci. 2000 Apr;903:176-9. Review.

PMID:
10818505
18.

Gene polymorphism in apolipoprotein E and presenilin-1 in patients with late-onset Alzheimer's disease.

Cui T, Zhou X, Jin W, Zheng F, Cao X.

Chin Med J (Engl). 2000 Apr;113(4):340-4.

PMID:
11775232
19.

Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.

Raygani AV, Zahrai M, Raygani AV, Doosti M, Javadi E, Rezaei M, Pourmotabbed T.

Neurosci Lett. 2005 Feb 25;375(1):1-6. Epub 2004 Nov 26.

PMID:
15664112
20.

[An association analysis of apolipoprotein E genotypes with Alzheimer's disease in Chinese population].

Wu YN, Zhang JW, Zhang ZX, Qu QM, Chen D.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2001 Oct;23(5):450-4. Chinese.

PMID:
12905860

Supplemental Content

Support Center